DE60104671D1 - Imidazopyrimidin-derivate und triazolopyrimidin-derivate - Google Patents

Imidazopyrimidin-derivate und triazolopyrimidin-derivate

Info

Publication number: DE60104671D1
Authority: DE; Germany
Prior art keywords: derivatives; imidazopyrimidine; triazolopyrimidine; triazolopyrimidine derivatives; imidazopyrimidine derivatives
Prior art date: 2000-04-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE60104671T

Other languages

English (en)

Other versions

DE60104671T2 (de

Inventor

Takeshi Yura

Arnel B Concepcion

Gyoonhee Han

Makiko Hiraoka

Hiroko Katsumata

Norihiro Kawamura

Toshio Kokubo

Hiroshi Komura

Yingfu Li

Timothy B Lowinger

Muneto Mogi

Noriyuki Yamamoto

Nagahiro Yoshida

Ming Wang

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bayer Pharmaceuticals Corp

Original Assignee

Bayer Healthcare AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-28

Filing date

2001-04-17

Publication date

2004-09-09

2001-04-17 Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG

2004-09-09 Application granted granted Critical

2004-09-09 Publication of DE60104671D1 publication Critical patent/DE60104671D1/de

2005-12-29 Publication of DE60104671T2 publication Critical patent/DE60104671T2/de

2021-04-18 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Hematology (AREA)
Dermatology (AREA)
Neurology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Ophthalmology & Optometry (AREA)
Transplantation (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Obesity (AREA)
Child & Adolescent Psychology (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Plural Heterocyclic Compounds (AREA)

DE60104671T 2000-04-28 2001-04-17 Imidazopyrimidin-derivate und triazolopyrimidin-derivate Expired - Fee Related DE60104671T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2000128870		2000-04-28
JP2000128870A JP2001302667A (ja)	2000-04-28	2000-04-28	イミダゾピリミジン誘導体およびトリアゾロピリミジン誘導体
PCT/EP2001/004357 WO2001083485A1 (en)	2000-04-28	2001-04-17	Imidazopyrimidine derivatives and triazolopyrimidine derivatives

Publications (2)

Publication Number	Publication Date
DE60104671D1 true DE60104671D1 (de)	2004-09-09
DE60104671T2 DE60104671T2 (de)	2005-12-29

Family

ID=18638240

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60104671T Expired - Fee Related DE60104671T2 (de)	2000-04-28	2001-04-17	Imidazopyrimidin-derivate und triazolopyrimidin-derivate

Country Status (37)

Country	Link
US (1)	US6911443B2 (de)
EP (1)	EP1278750B1 (de)
JP (2)	JP2001302667A (de)
KR (1)	KR20030009456A (de)
CN (1)	CN1263756C (de)
AR (1)	AR033367A1 (de)
AT (1)	ATE272639T1 (de)
AU (1)	AU783043B2 (de)
BG (1)	BG107166A (de)
BR (1)	BR0110404A (de)
CA (1)	CA2407531A1 (de)
CZ (1)	CZ20023551A3 (de)
DE (1)	DE60104671T2 (de)
DK (1)	DK1278750T3 (de)
DO (1)	DOP2001000151A (de)
EE (1)	EE200200606A (de)
ES (1)	ES2225546T3 (de)
HR (1)	HRP20020943A2 (de)
HU (1)	HUP0300846A2 (de)
IL (1)	IL151919A0 (de)
MA (1)	MA25746A1 (de)
MX (1)	MXPA02010579A (de)
MY (1)	MY141578A (de)
NO (1)	NO20025154L (de)
NZ (2)	NZ522241A (de)
PE (1)	PE20011287A1 (de)
PL (1)	PL358106A1 (de)
PT (1)	PT1278750E (de)
RU (1)	RU2306313C2 (de)
SI (1)	SI1278750T1 (de)
SK (1)	SK15332002A3 (de)
SV (1)	SV2001000416A (de)
TR (1)	TR200402300T4 (de)
TW (1)	TWI222974B (de)
UA (1)	UA72615C2 (de)
WO (1)	WO2001083485A1 (de)
ZA (1)	ZA200207676B (de)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1385823T3 (da)	2001-04-09	2007-03-26	Novartis Vaccines & Diagnostic	Guanidinoforbindelser som melanocortin-4-receptor- (MC4-R) -agonister
ATE316077T1 (de)	2003-04-25	2006-02-15	Actimis Pharmaceuticals Inc	Pyrimidin-essigsäure derivate geeignet zur behandlung von crth2-bedingten krankheiten
WO2005037837A1 (ja) *	2003-10-17	2005-04-28	Nippon Kayaku Kabushiki Kaisha	置換２−アミノ−[１，２，４]トリアゾロ[１，５−a]ピリミジン誘導体及びその用途
EP1694686A1 (de)	2003-12-19	2006-08-30	Takeda San Diego, Inc.	Kinaseinhibitoren
EP1718649B1 (de) *	2004-01-31	2009-06-10	Actimis Pharmaceuticals, Inc.,	Imidazo[1,2-c]pyrimidinylessigsäurederivate
CA2570319A1 (en) *	2004-06-25	2006-01-12	Amgen Inc.	Condensed triazoles and indazoles useful in treating citokines mediated diseases and other diseases
JP2008510734A (ja)	2004-08-18	2008-04-10	タケダサンディエゴインコーポレイテッド	キナーゼ阻害剤
MX2007002178A (es)	2004-08-23	2007-04-02	Wyeth Corp	Acidos de oxazolo-naftilo como moduladores del inhibidor del activador de plasminogeno tipo 1 (pai-1) util en el tratamiento de trombosis y enfermedades cardiovasculares.
US7605172B2 (en)	2004-08-23	2009-10-20	Wyeth	Thiazolo-naphthyl acids
WO2006023864A1 (en)	2004-08-23	2006-03-02	Wyeth	Pyrrolo-naphthyl acids as pai-1 inhibitors
US7713973B2 (en)	2004-10-15	2010-05-11	Takeda Pharmaceutical Company Limited	Kinase inhibitors
AU2006219231B2 (en)	2005-02-28	2010-01-14	Japan Tobacco Inc.	Novel aminopyridine compound with Syk inhibitory activity
US7442700B2 (en)	2005-07-01	2008-10-28	Bristol-Myers Squibb Company	Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith
US8119655B2 (en) *	2005-10-07	2012-02-21	Takeda Pharmaceutical Company Limited	Kinase inhibitors
AU2006301435A1 (en) *	2005-10-13	2007-04-19	Glaxo Group Limited	Pyrrolopyrimidine derivatives as Syk inhibitors
CL2007002617A1 (es) *	2006-09-11	2008-05-16	Sanofi Aventis	Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
EP2223925A1 (de) *	2006-10-09	2010-09-01	Takeda Pharmaceutical Company Limited	Kinase-Inhibitoren
EA200970361A1 (ru)	2006-10-09	2010-02-26	Такеда Фармасьютикал Компани Лимитед	Ингибиторы киназы
ME02372B (me) *	2006-11-22	2016-06-20	Incyte Holdings Corp	Imidazotriazini i imidazopiramidini kao inhibitori kinaze
KR20090103897A (ko)	2006-12-28	2009-10-01	다이쇼 세이야꾸 가부시끼가이샤	피라졸로피리미딘 화합물
DE102007012645A1 (de)	2007-03-16	2008-09-18	Bayer Healthcare Ag	Substituierte Imidazo- und Triazolopyrimidine
EP2205570B1 (de)	2007-09-25	2013-09-11	Actimis Pharmaceuticals, Inc.,	2-s-benzyl-substituierte pyrimidine als crth2-antagonisten
PT2205569E (pt)	2007-09-25	2012-05-25	Actimis Pharmaceuticals Inc	Alquiltiopirimidinas como antagonistas de crth2
DE102008023801A1 (de)	2008-05-15	2009-11-19	Bayer Schering Pharma Aktiengesellschaft	Substituierte Imidazo- und Triazolopyrimidine, Imidazo- und Pyrazolopyrazine und Imidazotriazine
DK2716157T3 (en)	2008-12-08	2016-08-15	Gilead Connecticut Inc	Imidazopyrazin-Syk inhibitors
CN104059073B (zh)	2008-12-08	2017-04-12	吉利德康涅狄格公司	咪唑并哌嗪syk抑制剂
EP2443123B1 (de)	2009-06-15	2017-04-05	Rigel Pharmaceuticals, Inc.	Kleinmolekül-hemmer der spleen-tyrosinkinase
PL2516434T3 (pl)	2009-12-23	2015-11-30	Takeda Pharmaceuticals Co	Skondensowane heteroaromatyczne pirolidynony jako inhibitory SYK
AU2011226689B2 (en)	2010-03-11	2016-09-01	Kronos Bio, Inc.	Imidazopyridines Syk inhibitors
US8962596B2 (en) *	2010-04-14	2015-02-24	Array Biopharma Inc.	5,7-substituted-imidazo[1,2-C]pyrimidines as inhibitors of JAK kinases
WO2012154520A1 (en)	2011-05-10	2012-11-15	Merck Sharp & Dohme Corp.	Pyridyl aminopyridines as syk inhibitors
US9145391B2 (en)	2011-05-10	2015-09-29	Merck Sharp & Dohme Corp.	Bipyridylaminopyridines as Syk inhibitors
RU2013154412A (ru)	2011-05-10	2015-06-20	Мерк Шарп И Доум Корп.	Аминопиримидины в качестве ингибиторов syc
WO2012167423A1 (en)	2011-06-08	2012-12-13	Hutchison Medipharma Limited	Substituted pyridopyrazines as novel syk inhibitors
EP2723739B1 (de)	2011-06-22	2016-08-24	Takeda Pharmaceutical Company Limited	Substituierte 6-aza-isoindolin-1-on-derivate
US9199975B2 (en)	2011-09-30	2015-12-01	Asana Biosciences, Llc	Biaryl imidazole derivatives for regulating CYP17
EP2763975B1 (de)	2011-10-05	2016-04-06	Merck Sharp & Dohme Corp.	3-pyridyl-carboxamidhaltige milztyrosinkinase-(syk)-hemmer
WO2013052394A1 (en)	2011-10-05	2013-04-11	Merck Sharp & Dohme Corp.	2-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
WO2013052391A1 (en)	2011-10-05	2013-04-11	Merck Sharp & Dohme Corp.	PHENYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (Syk) INHIBITORS
CN103987713A (zh) *	2011-10-12	2014-08-13	阵列生物制药公司	5,7-取代的咪唑并[1,2-c]嘧啶
WO2013099041A1 (ja) *	2011-12-28	2013-07-04	富士フイルム株式会社	新規なニコチンアミド誘導体またはその塩
WO2013192125A1 (en)	2012-06-20	2013-12-27	Merck Sharp & Dohme Corp.	Pyrazolyl derivatives as syk inhibitors
EP2863913B1 (de)	2012-06-20	2018-09-12	Merck Sharp & Dohme Corp.	Imidazolylanaloga als syk-hemmer
WO2013192088A1 (en)	2012-06-22	2013-12-27	Merck Sharp & Dohme Corp.	SUBSTITUTED DIAZINE AND TRIAZINE SPLEEN TYROSINE KINASE (Syk) INHIBITORS
WO2013192098A1 (en)	2012-06-22	2013-12-27	Merck Sharp & Dohme Corp.	SUBSTITUTED PYRIDINE SPLEEN TYROSINE KINASE (Syk) INHIBITORS
EP2884982B1 (de)	2012-08-20	2017-09-20	Merck Sharp & Dohme Corp.	Substituierte phenyl-milz-tyrosinkinaseinhibitoren
WO2014048065A1 (en)	2012-09-28	2014-04-03	Merck Sharp & Dohme Corp.	Triazolyl derivatives as syk inhibitors
WO2014093191A1 (en)	2012-12-12	2014-06-19	Merck Sharp & Dohme Corp.	AMINO-PYRIMIDINE-CONTAINING SPLEEN TYROSINE KINASE (Syk) INHIBITORS
EP2934525B1 (de)	2012-12-21	2019-05-08	Merck Sharp & Dohme Corp.	Thiazolsubstituierte aminopyridine als milztyrosinkinasehemmer
US9745295B2 (en)	2013-04-26	2017-08-29	Merck Sharp & Dohme Corp.	Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
US9499534B2 (en)	2013-04-26	2016-11-22	Merck Sharp & Dohme Corp.	Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors
AU2014296308C1 (en)	2013-07-30	2018-09-13	Kronos Bio, Inc.	Polymorph of Syk inhibitors
US9382256B2 (en)	2013-07-30	2016-07-05	Gilead Connecticut, Inc.	Formulation of Syk inhibitors
JP6298539B2 (ja)	2013-12-04	2018-03-20	ギリアードサイエンシーズ，インコーポレイテッド	がんを処置する方法
EP3082807B1 (de)	2013-12-20	2018-07-04	Merck Sharp & Dohme Corp.	Thiazolsubstituierte aminoheteroaryle als milztyrosinkinasehemmer
EP3083559B1 (de)	2013-12-20	2021-03-10	Merck Sharp & Dohme Corp.	Thiazolsubstituierte aminoheteroaryle als milztyrosinkinasehemmer
WO2015095444A1 (en)	2013-12-20	2015-06-25	Merck Sharp & Dohme Corp.	Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
UY35898A (es)	2013-12-23	2015-07-31	Gilead Sciences Inc	?compuestos inhibidores de syk y composiciones que los comprenden?.
US9290505B2 (en)	2013-12-23	2016-03-22	Gilead Sciences, Inc.	Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
WO2015138273A1 (en)	2014-03-13	2015-09-17	Merck Sharp & Dohme Corp.	2-pyrazine carboxamides as spleen tyrosine kinase inhibitors
EP3119765B1 (de)	2014-03-19	2019-07-17	Boehringer Ingelheim International GmbH	Heteroaryler syk-hemmer
EP3169366A1 (de)	2014-07-14	2017-05-24	Gilead Sciences, Inc.	Kombinationen zur behandlung von krebs
JP6868011B2 (ja)	2015-09-11	2021-05-12	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	ピラゾリル置換ヘテロアリール及び医薬としてのその使用
CN115028640A (zh)	2017-08-25	2022-09-09	吉利德科学公司	Syk抑制剂的多晶型物
BR112020007679A2 (pt)	2017-10-19	2020-10-20	Bayer Animal Health Gmbh	uso de pirrolidonas heteroaromáticas fundidas para tratamento e prevenção de doenças em animais.
KR20250030535A (ko) *	2017-11-14	2025-03-05	칠드런'즈 메디컬 센터 코포레이션	인간 면역 반응을 조정하기 위한 이미다조피리미딘의 용도
CN111936136B (zh)	2017-11-14	2024-07-05	儿童医学中心公司	新咪唑并嘧啶化合物及其用途
EP3804722A4 (de) *	2018-06-06	2022-04-13	National University Corporation Hokkaido University	Behandlungsmittel und pharmazeutische zusammensetzung für gliome
WO2019235571A1 (ja) *	2018-06-06	2019-12-12	富士フイルム株式会社	血液がんの処置剤および医薬組成物
WO2019235572A1 (ja) *	2018-06-06	2019-12-12	富士フイルム株式会社	固形がんの処置剤および医薬組成物
AU2019373221B2 (en)	2018-10-31	2022-05-26	Gilead Sciences, Inc.	Substituted 6-azabenzimidazole compounds having HPK1 inhibitory activity
IL282535B2 (en)	2018-10-31	2024-05-01	Gilead Sciences Inc	Transformed 6-azabanzimidazole compounds as HPK1 inhibitors
EP3927708A1 (de)	2019-02-22	2021-12-29	Kronos Bio, Inc.	Feste formen von kondensierten pyrazinen als syk-inhibitoren
CA3129665A1 (en)	2019-03-21	2020-09-24	Onxeo	A dbait molecule in combination with kinase inhibitor for the treatment of cancer
EP3972695A1 (de)	2019-05-23	2022-03-30	Gilead Sciences, Inc.	Substituierte exo-methylen-oxindole als hpk1/map4k1-inhibitoren
AU2020378630A1 (en)	2019-11-08	2022-05-26	INSERM (Institut National de la Santé et de la Recherche Médicale)	Methods for the treatment of cancers that have acquired resistance to kinase inhibitors
WO2021148581A1 (en)	2020-01-22	2021-07-29	Onxeo	Novel dbait molecule and its use
WO2021173476A1 (en) *	2020-02-24	2021-09-02	The Trustees Of Columbia University In The City Of New York	Compounds, pharmaceutical formulations, and methods for treatment of cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4483987A (en) *	1983-06-20	1984-11-20	G. D. Searle & Co.	8-Substituted 7-phenyl-1,2,4-triazolo[2,3-c]pyrimidines-5-amines and amides
FR2549834B1 (fr) *	1983-07-25	1985-10-18	Sanofi Sa	Derives de triazolo-pyrimidine, leur procede de preparation et leur application therapeutique en tant que tonicardiaques
WO1999016755A1 (en) *	1997-09-26	1999-04-08	Merck & Co., Inc.	Novel angiogenesis inhibitors
WO1999031073A1 (fr) *	1997-12-15	1999-06-24	Yamanouchi Pharmaceutical Co., Ltd.	Nouveaux derives de pyrimidine-5-carboxamide
US6673564B2 (en) *	1999-10-18	2004-01-06	Millennium Pharmaceuticals, Inc.	Methods for using 22045, a human cyclic nucleotide phosphodiesterase

2000
- 2000-04-28 JP JP2000128870A patent/JP2001302667A/ja active Pending
2001
- 2001-04-17 SK SK1533-2002A patent/SK15332002A3/sk unknown
- 2001-04-17 IL IL15191901A patent/IL151919A0/xx unknown
- 2001-04-17 BR BR0110404-7A patent/BR0110404A/pt not_active IP Right Cessation
- 2001-04-17 EP EP01936242A patent/EP1278750B1/de not_active Expired - Lifetime
- 2001-04-17 HU HU0300846A patent/HUP0300846A2/hu unknown
- 2001-04-17 CA CA002407531A patent/CA2407531A1/en not_active Abandoned
- 2001-04-17 HR HR20020943A patent/HRP20020943A2/hr not_active Application Discontinuation
- 2001-04-17 DK DK01936242T patent/DK1278750T3/da active
- 2001-04-17 AT AT01936242T patent/ATE272639T1/de not_active IP Right Cessation
- 2001-04-17 PT PT01936242T patent/PT1278750E/pt unknown
- 2001-04-17 WO PCT/EP2001/004357 patent/WO2001083485A1/en active IP Right Grant
- 2001-04-17 TR TR2004/02300T patent/TR200402300T4/xx unknown
- 2001-04-17 NZ NZ522241A patent/NZ522241A/en unknown
- 2001-04-17 UA UA2002119418A patent/UA72615C2/uk unknown
- 2001-04-17 CZ CZ20023551A patent/CZ20023551A3/cs unknown
- 2001-04-17 PL PL01358106A patent/PL358106A1/xx not_active Application Discontinuation
- 2001-04-17 ES ES01936242T patent/ES2225546T3/es not_active Expired - Lifetime
- 2001-04-17 RU RU2002132193/04A patent/RU2306313C2/ru not_active IP Right Cessation
- 2001-04-17 SI SI200130178T patent/SI1278750T1/xx unknown
- 2001-04-17 CN CNB018117201A patent/CN1263756C/zh not_active Expired - Fee Related
- 2001-04-17 AU AU62204/01A patent/AU783043B2/en not_active Ceased
- 2001-04-17 US US10/258,628 patent/US6911443B2/en not_active Expired - Fee Related
- 2001-04-17 DE DE60104671T patent/DE60104671T2/de not_active Expired - Fee Related
- 2001-04-17 NZ NZ526221A patent/NZ526221A/en unknown
- 2001-04-17 KR KR1020027014441A patent/KR20030009456A/ko not_active Ceased
- 2001-04-17 EE EEP200200606A patent/EE200200606A/xx unknown
- 2001-04-17 MX MXPA02010579A patent/MXPA02010579A/es active IP Right Grant
- 2001-04-17 JP JP2002500795A patent/JP2003535067A/ja active Pending
- 2001-04-25 DO DO2001000151A patent/DOP2001000151A/es unknown
- 2001-04-26 MY MYPI20011983A patent/MY141578A/en unknown
- 2001-04-27 PE PE2001000382A patent/PE20011287A1/es not_active Application Discontinuation
- 2001-04-27 SV SV2001000416A patent/SV2001000416A/es not_active Application Discontinuation
- 2001-04-27 TW TW090110055A patent/TWI222974B/zh not_active IP Right Cessation
- 2001-04-27 AR ARP010102006A patent/AR033367A1/es not_active Application Discontinuation
2002
- 2002-09-25 ZA ZA200207676A patent/ZA200207676B/xx unknown
- 2002-10-03 BG BG107166A patent/BG107166A/bg unknown
- 2002-10-25 NO NO20025154A patent/NO20025154L/no not_active Application Discontinuation
- 2002-10-28 MA MA26885A patent/MA25746A1/fr unknown

Also Published As

Publication number	Publication date
DE60104671T2 (de)	2005-12-29
NZ522241A (en)	2004-04-30
BR0110404A (pt)	2003-02-11
EP1278750A1 (de)	2003-01-29
NO20025154D0 (no)	2002-10-25
JP2003535067A (ja)	2003-11-25
RU2306313C2 (ru)	2007-09-20
KR20030009456A (ko)	2003-01-29
TR200402300T4 (tr)	2004-12-21
MA25746A1 (fr)	2003-04-01
UA72615C2 (en)	2005-03-15
EP1278750B1 (de)	2004-08-04
US6911443B2 (en)	2005-06-28
AU6220401A (en)	2001-11-12
CN1439009A (zh)	2003-08-27
BG107166A (bg)	2003-06-30
CA2407531A1 (en)	2001-10-25
TWI222974B (en)	2004-11-01
DOP2001000151A (es)	2002-05-15
ATE272639T1 (de)	2004-08-15
AU783043B2 (en)	2005-09-22
DK1278750T3 (da)	2004-11-22
CN1263756C (zh)	2006-07-12
IL151919A0 (en)	2003-04-10
ZA200207676B (en)	2003-09-25
NO20025154L (no)	2002-10-25
CZ20023551A3 (cs)	2003-01-15
MXPA02010579A (es)	2003-05-14
PL358106A1 (en)	2004-08-09
PT1278750E (pt)	2004-11-30
WO2001083485A1 (en)	2001-11-08
HRP20020943A2 (en)	2005-02-28
EE200200606A (et)	2004-04-15
SK15332002A3 (sk)	2003-06-03
NZ526221A (en)	2005-01-28
JP2001302667A (ja)	2001-10-31
ES2225546T3 (es)	2005-03-16
SI1278750T1 (en)	2005-02-28
MY141578A (en)	2010-05-14
HK1058362A1 (en)	2004-05-14
PE20011287A1 (es)	2002-02-27
US20040054179A1 (en)	2004-03-18
AR033367A1 (es)	2003-12-17
HUP0300846A2 (hu)	2003-08-28
SV2001000416A (es)	2001-07-03

Publication	Publication Date	Title
DE60104671D1 (de)	2004-09-09	Imidazopyrimidin-derivate und triazolopyrimidin-derivate
AR028622A1 (es)	2003-05-14	Derivados de tropano utiles en terapia
DE50112013D1 (de)	2007-03-22	Deodorantien und antiperspirantien
DE60120268D1 (de)	2006-07-20	Fahrrad und Fahrradfaltverfahren
MA26612A1 (fr)	2004-12-20	Pyrazolopyrimidines et pyrazolotriazines
ATE306318T1 (de)	2005-10-15	Entschwefelung und hierfür geeignetes sorbens
DE60026297D1 (de)	2006-04-27	Pyrrolotriazin kinasehemmer
DE60027759D1 (de)	2006-06-08	Absorbierender artikel
DE60005810D1 (de)	2003-11-13	Fussstütze und möbelstück
DE60020536D1 (de)	2005-07-07	Absorbierender artikel
DE60039814D1 (de)	2008-09-25	Absorbierender Artikel
DE60018133D1 (de)	2005-03-24	Absorbierender Artikel
FR2801195B3 (fr)	2001-11-02	Article absorbant
DE60030038D1 (de)	2006-09-28	Absorbierender Artikel
DE60044183D1 (de)	2010-05-27	Absorbierender artikel
DE60038972D1 (de)	2008-07-03	Absorbierender artikel
DE60020737D1 (de)	2005-07-14	Sic-einkristall und herstellungsverfahren dafür
FR2809684B1 (fr)	2002-10-11	Accoudoir escamotable
DE60032898D1 (de)	2007-02-22	Arylthiazolidindion- und aryloxazolidinderivate
ATE242051T1 (de)	2003-06-15	Mykotoxin-adsorbens
ATE512148T1 (de)	2011-06-15	Pyrazolo- und imidazopyrimidinderivate
DE60103909D1 (de)	2004-07-22	2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on- und 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5 1honderivate
NO20020873L (no)	2002-04-18	Omfestbar absorberende artikkel
DE50208341D1 (de)	2006-11-16	Triazolopyrimidine
NO20004072D0 (no)	2000-08-15	Absorberende artikkel

Legal Events

Date	Code	Title	Description
2005-09-01	8364	No opposition during term of opposition
2005-09-15	8327	Change in the person/name/address of the patent owner	Owner name: BAYER PHARMACEUTICALS CORP., WEST HAVEN, CONN., US
2011-02-17	8339	Ceased/non-payment of the annual fee